• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Anticoagulation for Stroke Prevention in Atrial Fibrillation
This article reviews strategies for the use of anticoagulation and highlights the nurse ’s role in patient education.
Source: Nursing Clinics of North America - June 16, 2023 Category: Nursing Authors: Carrie Palmer Source Type: research

Atrial Fibrillation: An Update for Home Healthcare Clinicians
This article reviews the guideline for the management of patients with atrial fibrillation by the American College of Cardiology and American Heart Association Task Force on Clinical Practice Guidelines and provides recommendations for home healthcare clinicians.
Source: Home Healthcare Nurse - January 1, 2021 Category: Nursing Tags: Feature: NCPD Connection Source Type: research

Guideline-based Management of Patients With Atrial Fibrillation
Atrial fibrillation (AF) has become a significant public health concern. An epidemiologic study conducted in 2010 estimated there are over 33.5 million people worldwide diagnosed with AF with that number predicted to rise by 5% annually. In the United States, AF is the primary diagnosis in over 500,000 hospital admissions annually. Guideline-based knowledge of treatment options is imperative in decreasing stroke risk, prevention of worsening heart function, and maintaining quality of life. It is also important for nurse practitioners to have this knowledge to make educated treatment recommendations to keep our patients saf...
Source: The Journal for Nurse Practitioners - November 20, 2018 Category: Nursing Authors: Christine Tacklind Tags: Feature Article Source Type: research

Stop Bleeding! Oral  Anticoagulation and Options for Reversal
Direct oral anticoagulants (DOACs) are widely used medications for stroke prevention in nonvalvular atrial fibrillation (AF), and for deep vein thrombosis treatment and prevention. The IMS Institute for Healthcare Informatics analyzed outpatient anticoagulant use in the United States between 2009 and 2014 and found that there has been a steady increase in DOAC use following their initial approval in 2010.1 DOACs include the direct thrombin inhibitor dabigatran, and the factor Xa inhibitors rivaroxaban, apixaban, and edoxaban, and recently approved betrixaban.
Source: The Journal for Nurse Practitioners - November 29, 2017 Category: Nursing Authors: Archna Jariwala, Kori Hamman Tags: Prescription Pad Source Type: research